Africa
ZMapp trials start in Liberia
March 2, 2015Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp
Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …
Resistance threat to malaria drug is ‘alarming’
February 20, 2015Research and Development, Sales and Marketing Africa, Qinghaosu, artemisinin, malaria, thailand
Resistance to a group of drugs that possess the most rapid action against malaria – artemisinin, aka Qinghaosu – is …
Scientists warn Ebola virus is mutating
January 29, 2015Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, Institut Pasteur, J&J, JJ, guinea
Researchers in France studying the Ebola epidemic say the virus has mutated making it potentially even more contagious. Scientists based …
GSK launches Ebola Phase III trial in Liberia
January 23, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink
A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
UK nurse with Ebola in ‘critical condition’
January 6, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp
A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …
New hope through Ebola vaccine trial
December 23, 2014Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda
A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
GSK tops pharma league for access
November 17, 2014Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines
GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
J&J fast-track Ebola vaccine for early 2015 trials
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, Mapp, zmapp
Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …
GSK Ebola vaccine fast-tracked into human trials
August 28, 2014Sales and Marketing Africa, Ebola, GSK, WHO, zmapp
GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …
UK nurse with Ebola given new drug in London
August 27, 2014Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp
A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after …
Wellcome Trust makes Ebola research investment
August 21, 2014Research and Development, Sales and Marketing Africa, Ebola, Nigeria, deltas, welcome trust
The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment …
Sanofi and PATH launch large-scale malaria drug production
August 19, 2014Manufacturing and Production, Sales and Marketing Africa, Sanofi, acts, artemisinin, malaria, path
Sanofi and global health charity PATH have come together to launch a large-scale production line of malaria jab semisynthetic artemisinin …
Untested Ebola drugs can be used in Africa
August 13, 2014Research and Development, Sales and Marketing Africa, Biocryst Pharmaceuticals, Ebola, Siga Technologies, Tekmira Pharmaceuticals, WHO, world health organization, zmapp
The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
